Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: RCJIII who wrote (28437)	7/6/1998 11:50:00 AM
From: Logistics	Respond to of 34592

BLUD Update from another thread. By the way, I have followed this stock and spoken in length to the company months ago. Implications for their technology is huge. Could eliminate need for lab techs etc.... I agree on the 15.00 prediction short term. Buying here. JL Immucor (BLUD), no hope for a 50 bagger but check it out, it's money in the bank. FDA this morning approved the 3-year-old application for a machine that automates all blood testing procedures at a huge savings of time and labor, and with more accurate results. Up only from 8 1/2 to 10 as of right now. The inventory is going to run out in a few hours and this one's gonna' pop. Ought to see 15 fast.

To: RCJIII who wrote (28437)	7/6/1998 11:53:00 AM
From: Logistics	Read Replies (2) \| Respond to of 34592

mmucor's ABS2000 Cleared by FDA For Use in U.S. First Fully Automated Blood Bank System Increases Safety and Productivity NORCROSS, Ga., July 6 /PRNewswire/ -- Immucor, Inc. (Nasdaq: BLUD), maker of blood bank reagents and related products, announced today that the U.S. Food and Drug Administration (FDA) has cleared the ABS2000 for marketing in the United States. The ABS2000 is the first fully automated, walk-away instrument for the hospital blood bank transfusion laboratory. Commenting on this clearance, Edward L. Gallup, President, stated, "This is a major milestone in the history of Immucor. The ABS2000 offers our customers significant labor reduction while increasing productivity and patient safety. This system completes our instrument family which also includes the DIAS PLUS and the Rosys Plato. We are the only company with automated solutions for the three market segments; hospital blood banks, donor centers and reference laboratories." Commenting further, Mr. Gallup stated, "The ABS2000 is our flagship product. There are more than 2,500 facilities in the U.S. that can benefit from the quality and productivity improvements provided by the ABS2000. We believe we have a major advantage in the U.S. market as we are not aware of any competitive instrument which will enter the market in the foreseeable future. There are currently over 20,000 patient test results reported monthly on the ABS2000 placements in Europe and Canada." Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of our market segments. For more information on Immucor, please visit the Company's website at www.immucor.com. This press release may contain forward-looking statements as that term is defined in the Private Securities Reform Act of 1995, including, without limitation, statements concerning the Company's expectations, beliefs, intentions or strategies regarding the future. All forward-looking statements included in this document are based on information available to the Company on the date hereof, and the Company assumes no obligation to update any such forward-looking statements. Further risks are detailed in the Company's filings with the Securities and Exchange Commission, including those set forth in the Company's most recent Form 10-K and Quarterly Reports on Form 10-Q.

To: RCJIII who wrote (28437)	7/6/1998 12:44:00 PM
From: Norms	Respond to of 34592

Looks like TSIG is off to a great start this week. Longer than ever on this one. Many folks have taken today for a July 4th extended holiday. Wait till they see the TSIG fireworks! The coolest thing for TSIG investors is that it's value should continue to rise significantly after the opening of the web site. Most "event stocks" fall sharply after the event and the news. For TSIG, the "event" sets the stage for huge things to come: - Many won't even invest until they see the site up and running - Media and marketing blitz kicks in on National TV, Radio, the Internet, Music Magazines, etc. - Word spreads through the HOT Music Internet Sector (CDNow, N2K, KTEL, Amazon.com, etc.) - Exposure in the Investment Press (Investors Business Daily, etc.) - Add to all of this the teleservices business announcements I see many, many dollars attached to the current price of TSIG. For your investment bang-for-the-buck - TSIG's potential is staggering! Good luck to all.............Norms